Turn Therapeutics (TTRX) Equity Ratio (2024 - 2026)

Turn Therapeutics' Equity Ratio history runs 3 years deep, the most recent figure standing at 0.33 for Q1 2026.

• In Q1 2026, Equity Ratio changed N/A year-over-year to 0.33; the TTM figure through Mar 2026 stood at 0.33 (changed N/A YoY), while the FY2025 annual figure was 0.39, up 544.98% from the prior year.
• Equity Ratio was 0.33 for Q1 2026 at Turn Therapeutics, down from 0.39 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.39 in Q4 2025 to a low of 0.09 in Q4 2024.
• Historically, Equity Ratio has averaged 0.19 across 3 years, with a median of 0.22 in 2025.
• Biggest YoY gain for Equity Ratio was 544.98% in 2025; the steepest drop was 544.98% in 2025.
• A 3-year view of Equity Ratio shows it stood at 0.09 in 2024, then surged by 544.98% to 0.39 in 2025, then declined by 14.85% to 0.33 in 2026.
• The last three Equity Ratio figures came in at 0.33 (Q1 2026), 0.39 (Q4 2025), and 0.12 (Q3 2025), per Business Quant data.